Table 2

Proximity of SIV, MLV, and ASLV insertions to oncogenes

SIV
MLV
ASLV
6-12 months SIVMatching randomsP vs randoms35-47 months SIVMatching randomsP vs randomsAll SIVMatching randomsP vs randomsAll MLVMatching randomsP vs randomsAll ASLVMatching randomsP vs randoms
Total mapped integrations 289   267   519   396   198   
No. of integrations within 30 kb of 1 or more oncogenes* 13 4.29 < .001 15 3.96 < .001 26 7.69 < .001 16 5.66 < .001 3.14 .392 
No. of integrations within 30 kb of 1 or more genes 272 152 < .001 252 140 < .001 490 273 < .001 304 202 < .001 137 107 < .001 
% of sites (within 30 kb of gene) that are within 30 kb of oncogene 4.8% 2.8% .084 5.9% 2.8% .022 5.3% 2.8% .014 5.3% 2.8% .028 1.5% 2.9% .178 
SIV
MLV
ASLV
6-12 months SIVMatching randomsP vs randoms35-47 months SIVMatching randomsP vs randomsAll SIVMatching randomsP vs randomsAll MLVMatching randomsP vs randomsAll ASLVMatching randomsP vs randoms
Total mapped integrations 289   267   519   396   198   
No. of integrations within 30 kb of 1 or more oncogenes* 13 4.29 < .001 15 3.96 < .001 26 7.69 < .001 16 5.66 < .001 3.14 .392 
No. of integrations within 30 kb of 1 or more genes 272 152 < .001 252 140 < .001 490 273 < .001 304 202 < .001 137 107 < .001 
% of sites (within 30 kb of gene) that are within 30 kb of oncogene 4.8% 2.8% .084 5.9% 2.8% .022 5.3% 2.8% .014 5.3% 2.8% .028 1.5% 2.9% .178 

Based on previously published rhesus macaque MLV and ASLV datasets (Hematti et al16 ; Hu et al36 ). Bold type indicates significant at level of < .05.

*

As defined by the July 14, 2008, version of the Sanger Cancer Gene Census.40 

As defined by the Macaca mulatta gene set from Ensembl.31 

Close Modal

or Create an Account

Close Modal
Close Modal